ArticleeLife2022

P2Y1 purinergic receptor identified as a diabetes target in a small-molecule screen to reverse circadian β-cell failure.

Biliana Marcheva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.